Matthew T Rondina1,2,3, Deepak Voora4, Lukas M Simon5, Hansjörg Schwertz1,2,6, Julie F Harper1, Olivia Lee1, Seema C Bhatlekar1, Qing Li7, Alicia S Eustes1, Emilie Montenont1, Robert A Campbell1,2, Neal D Tolley1, Yasuhiro Kosaka1, Andrew S Weyrich1,2, Paul F Bray1,2, Jesse W Rowley1,2. 1. From the Molecular Medicine Program (M.T.R., H.S., J.F.H., O.L., S.C.B., A.S.E., E.M., R.A.C., N.D.T., Y.K., A.S.W., P.F.B., J.W.R.). 2. Department of Internal Medicine (M.T.R., H.S., R.A.C., A.S.W., P.F.B., J.W.R.). 3. George E. Wahlen VAMC Geriatric Research and Education Clinical Center (M.T.R.). 4. Duke Center for Applied Genomics & Precision Medicine, Durham, NC (D.V.). 5. Helmholtz Zentrum München, German Research Center for Environmental Health, Institute of Computational Biology, Neuherberg, Germany (L.M.S.). 6. Rocky Mountain Center for Occupational and Environmental Health, The University of Utah, Salt Lake City (H.S.). 7. Huntsman Cancer Institute, Salt Lake City, Utah (Q.L.).
Abstract
RATIONALE: Longitudinal studies are required to distinguish within versus between-individual variation and repeatability of gene expression. They are uniquely positioned to decipher genetic signal from environmental noise, with potential application to gene variant and expression studies. However, longitudinal analyses of gene expression in healthy individuals-especially with regards to alternative splicing-are lacking for most primary cell types, including platelets. OBJECTIVE: To assess repeatability of gene expression and splicing in platelets and use repeatability to identify novel platelet expression quantitative trait loci (QTLs) and splice QTLs. METHODS AND RESULTS: We sequenced the transcriptome of platelets isolated repeatedly up to 4 years from healthy individuals. We examined within and between individual variation and repeatability of platelet RNA expression and exon skipping, a readily measured alternative splicing event. We find that platelet gene expression is generally stable between and within-individuals over time-with the exception of a subset of genes enriched for the inflammation gene ontology. We show an enrichment among repeatable genes for associations with heritable traits, including known and novel platelet expression QTLs. Several exon skipping events were also highly repeatable, suggesting heritable patterns of splicing in platelets. One of the most repeatable was exon 14 skipping of SELP. Accordingly, we identify rs6128 as a platelet splice QTL and define an rs6128-dependent association between SELP exon 14 skipping and race. In vitro experiments demonstrate that this single nucleotide variant directly affects exon 14 skipping and changes the ratio of transmembrane versus soluble P-selectin protein production. CONCLUSIONS: We conclude that the platelet transcriptome is generally stable over 4 years. We demonstrate the use of repeatability of gene expression and splicing to identify novel platelet expression QTLs and splice QTLs. rs6128 is a platelet splice QTL that alters SELP exon 14 skipping and soluble versus transmembrane P-selectin protein production.
RATIONALE: Longitudinal studies are required to distinguish within versus between-individual variation and repeatability of gene expression. They are uniquely positioned to decipher genetic signal from environmental noise, with potential application to gene variant and expression studies. However, longitudinal analyses of gene expression in healthy individuals-especially with regards to alternative splicing-are lacking for most primary cell types, including platelets. OBJECTIVE: To assess repeatability of gene expression and splicing in platelets and use repeatability to identify novel platelet expression quantitative trait loci (QTLs) and splice QTLs. METHODS AND RESULTS: We sequenced the transcriptome of platelets isolated repeatedly up to 4 years from healthy individuals. We examined within and between individual variation and repeatability of platelet RNA expression and exon skipping, a readily measured alternative splicing event. We find that platelet gene expression is generally stable between and within-individuals over time-with the exception of a subset of genes enriched for the inflammation gene ontology. We show an enrichment among repeatable genes for associations with heritable traits, including known and novel platelet expression QTLs. Several exon skipping events were also highly repeatable, suggesting heritable patterns of splicing in platelets. One of the most repeatable was exon 14 skipping of SELP. Accordingly, we identify rs6128 as a platelet splice QTL and define an rs6128-dependent association between SELP exon 14 skipping and race. In vitro experiments demonstrate that this single nucleotide variant directly affects exon 14 skipping and changes the ratio of transmembrane versus soluble P-selectin protein production. CONCLUSIONS: We conclude that the platelet transcriptome is generally stable over 4 years. We demonstrate the use of repeatability of gene expression and splicing to identify novel platelet expression QTLs and splice QTLs. rs6128 is a platelet splice QTL that alters SELP exon 14 skipping and soluble versus transmembrane P-selectin protein production.
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer Journal: Clin Chem Date: 2009-02-26 Impact factor: 8.327
Authors: Nadejda Beliakova-Bethell; Marta Massanella; Cory White; Steven Lada; Pinyi Du; Florin Vaida; Julià Blanco; Celsa A Spina; Christopher H Woelk Journal: Cytometry A Date: 2013-09-20 Impact factor: 4.355
Authors: Alan Penman; Suzanne Hoadley; James G Wilson; Herman A Taylor; Ching J Chen; Lucia Sobrin Journal: Am J Ophthalmol Date: 2015-03-17 Impact factor: 5.258
Authors: Hansjörg Schwertz; Neal D Tolley; Jason M Foulks; Melvin M Denis; Ben W Risenmay; Michael Buerke; Rachel E Tilley; Matthew T Rondina; Estelle M Harris; Larry W Kraiss; Nigel Mackman; Guy A Zimmerman; Andrew S Weyrich Journal: J Exp Med Date: 2006-10-23 Impact factor: 14.307
Authors: Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis Journal: Nature Date: 2015-10-01 Impact factor: 49.962
Authors: Myron G Best; Nik Sol; Sjors G J G In 't Veld; Adrienne Vancura; Mirte Muller; Anna-Larissa N Niemeijer; Aniko V Fejes; Lee-Ann Tjon Kon Fat; Anna E Huis In 't Veld; Cyra Leurs; Tessa Y Le Large; Laura L Meijer; Irsan E Kooi; François Rustenburg; Pepijn Schellen; Heleen Verschueren; Edward Post; Laurine E Wedekind; Jillian Bracht; Michelle Esenkbrink; Leon Wils; Francesca Favaro; Jilian D Schoonhoven; Jihane Tannous; Hanne Meijers-Heijboer; Geert Kazemier; Elisa Giovannetti; Jaap C Reijneveld; Sander Idema; Joep Killestein; Michal Heger; Saskia C de Jager; Rolf T Urbanus; Imo E Hoefer; Gerard Pasterkamp; Christine Mannhalter; Jose Gomez-Arroyo; Harm-Jan Bogaard; David P Noske; W Peter Vandertop; Daan van den Broek; Bauke Ylstra; R Jonas A Nilsson; Pieter Wesseling; Niki Karachaliou; Rafael Rosell; Elizabeth Lee-Lewandrowski; Kent B Lewandrowski; Bakhos A Tannous; Adrianus J de Langen; Egbert F Smit; Michel M van den Heuvel; Thomas Wurdinger Journal: Cancer Cell Date: 2017-08-14 Impact factor: 31.743
Authors: Benjamin B Sun; Joseph C Maranville; James E Peters; David Stacey; James R Staley; James Blackshaw; Stephen Burgess; Tao Jiang; Ellie Paige; Praveen Surendran; Clare Oliver-Williams; Mihir A Kamat; Bram P Prins; Sheri K Wilcox; Erik S Zimmerman; An Chi; Narinder Bansal; Sarah L Spain; Angela M Wood; Nicholas W Morrell; John R Bradley; Nebojsa Janjic; David J Roberts; Willem H Ouwehand; John A Todd; Nicole Soranzo; Karsten Suhre; Dirk S Paul; Caroline S Fox; Robert M Plenge; John Danesh; Heiko Runz; Adam S Butterworth Journal: Nature Date: 2018-06-06 Impact factor: 49.962
Authors: Monique R O Trugilho; Isaclaudia G Azevedo-Quintanilha; João S M Gesto; Emilly Caroline S Moraes; Samuel C Mandacaru; Mariana M Campos; Douglas M Oliveira; Suelen S G Dias; Viviane A Bastos; Marlon D M Santos; Paulo C Carvalho; Richard H Valente; Eugenio D Hottz; Fernando A Bozza; Thiago Moreno L Souza; Jonas Perales; Patrícia T Bozza Journal: Cell Death Discov Date: 2022-07-16
Authors: Sarah M Brotman; Chelsea K Raulerson; Swarooparani Vadlamudi; Kevin W Currin; Qiujin Shen; Victoria A Parsons; Apoorva K Iyengar; Tamara S Roman; Terrence S Furey; Johanna Kuusisto; Francis S Collins; Michael Boehnke; Markku Laakso; Päivi Pajukanta; Karen L Mohlke Journal: Am J Hum Genet Date: 2022-01-06 Impact factor: 11.043
Authors: Marzieh Ezzaty Mirhashemi; Ravi V Shah; Robert R Kitchen; Jian Rong; Aferdita Spahillari; Alexander R Pico; Olga Vitseva; Daniel Levy; Danielle Demarco; Sajani Shah; Mark D Iafrati; Martin G Larson; Kahraman Tanriverdi; Jane E Freedman Journal: Arterioscler Thromb Vasc Biol Date: 2020-12-10 Impact factor: 8.311
Authors: Emilie Montenont; Seema Bhatlekar; Shancy Jacob; Yasuhiro Kosaka; Bhanu K Manne; Olivia Lee; Ivan Parra-Izquierdo; Emilia Tugolukova; Neal D Tolley; Matthew T Rondina; Paul F Bray; Jesse W Rowley Journal: Blood Adv Date: 2021-05-11
Authors: Ahmed B Alarabi; Attayeb Mohsen; Kenji Mizuguchi; Fatima Z Alshbool; Fadi T Khasawneh Journal: BMC Med Genomics Date: 2022-04-14 Impact factor: 3.622
Authors: Travis M Griffiths; Lauren Page; Andrew S Weyrich; Matthew T Rondina; Robert A Campbell Journal: Thromb Res Date: 2020-12-18 Impact factor: 3.944